Skip to main content
Scope Fluidics S.A. logo

Scope Fluidics S.A. — Investor Relations & Filings

Ticker · SCP ISIN · PLSCPFL00018 LEI · 259400EUNFX4E2BEHU15 WAR Professional, scientific and technical activities
Open in API
Filings indexed 518 across all filing types
Latest filing 2025-12-16 Major Shareholding Noti…
Country PL Poland
Listing WAR SCP

About Scope Fluidics S.A.

https://scopefluidics.com/

Scope Fluidics S.A. is a biotechnology company that develops innovative medical diagnostic solutions based on microfluidic technologies. The company's business model involves incubating projects within special-purpose vehicles (SPVs) with the goal of selling them to global strategic partners. Its primary project, developed by its subsidiary Bacteromic Sp. z o.o., is the BACTEROMIC system. This automated system provides rapid, comprehensive antimicrobial susceptibility testing (AST) to address the challenge of antibiotic resistance. Previously, the company developed the PCR|ONE system for rapid molecular diagnostics through its Curiosity Diagnostics SPV, which was acquired by Bio-Rad in 2022. The company focuses on creating fast, effective, and accessible diagnostic tools to improve healthcare outcomes.

Recent filings

Filing Released Lang Actions
zal01_SCP_rbESPI_art._69uop_Piotr_Garstecki.pdf
Major Shareholding Notification Classification · 100% confidence The document is a formal notification ('Zawiadomienie') submitted by a shareholder (Piotr Garstecki) regarding a change in their shareholding in the company Scope Fluidics S.A. It references 'art. 69 ust. 1 lub 2' of the Polish Act on Public Offering, which is the standard regulatory requirement for disclosing significant changes in share ownership (crossing thresholds). This fits the definition of a Major Shareholding Notification.
2025-12-16 Polish
Otrzymanie zawiadomień z art. 69 ustawy o ofercie - Content (PL)
Regulatory Filings Classification · 95% confidence The document is very short (124 characters) and explicitly states that the company is attaching notifications received under Article 69 of the Act on Public Offering, which refers to major shareholding notifications. Since the document serves as a notification that these reports are being provided/attached rather than being the comprehensive major shareholding report itself, it falls under the Report Publication Announcement category.
2025-12-16 Polish
zal01_SCP_rbESPI_art.19MAR_Marcin_Izydorzak.pdf
Director's Dealing Classification · 100% confidence The document is a formal notification of a transaction by a person discharging managerial responsibilities (PDMR), specifically the Vice President (Wiceprezes) of Scope Fluidics S.A. It explicitly references Article 19(1) of the Market Abuse Regulation (MAR). This type of disclosure, detailing the individual's name, position, issuer details, and the nature of the transaction (return of borrowed shares), is a standard 'Director's Dealing' or 'PDMR Notification' filing.
2025-12-16 Polish
zal02_SCP_rbESPI_art.19MAR_Piotr_Garstecki.pdf
Director's Dealing Classification · 100% confidence The document is a formal notification of a transaction by a person discharging managerial responsibilities (PDMR), specifically the CEO (Prezes Zarządu) of Scope Fluidics S.A. It explicitly references Article 19(1) of the Market Abuse Regulation (MAR). This type of disclosure, where an executive reports their personal dealings in company shares, is classified as a Director's Dealing.
2025-12-16 Polish
Otrzymanie zawiadomień z art. 19 MAR - Content (PL)
Regulatory Filings Classification · 95% confidence The document is very short (111 characters) and explicitly states that it is transmitting notifications received under Article 19 of the Market Abuse Regulation (MAR). Article 19 MAR typically refers to notifications of transactions by persons discharging managerial responsibilities (PDMRs), which are director dealings. Since the document acts as a notification of these filings rather than the detailed transaction report itself, and given the brevity, it fits the criteria for a regulatory filing announcement.
2025-12-16 Polish
Warunkowe przyznanie dofinansowania dla Hybolic - Content (PL)
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding a conditional grant award from a government agency (PARP) to a subsidiary of the company. It describes a specific business development/financing event rather than a full financial report, proxy, or governance document. Since it does not fit into specific categories like M&A, dividends, or share issues, and is a standard corporate announcement of a material event, it falls under the general regulatory filing category.
2025-12-12 Polish

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.